Elderberry for Immune Support

NCT05435144 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2022-10-12

No results posted yet for this study

Summary

The purpose of this study is to confirm and quantify the effects of ElderCraft® elderberry extract on immune health.

Conditions

Interventions

DIETARY_SUPPLEMENT

Elderberry

European black elderberry extract

OTHER

Placebo

Inactive placebo

Sponsors & Collaborators

  • Artemis International

    collaborator UNKNOWN
  • IPRONA

    collaborator UNKNOWN
  • Nutraceuticals Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-26
Primary Completion
2023-03-28
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05435144 on ClinicalTrials.gov